Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Use of Brain Activity Monitoring for Early Identification of Pharmaceutical Treatment Efficacy and Development of Depression Deterioration Events.

NCT02523105 is registered in ClinicalTrials.gov with Brainmarc Ltd. as lead sponsor.

NCT NCT02523105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02523105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Use of Brain Activity Monitoring for Early Identification of Pharmaceutical Treatment Efficacy and Development of Depression Deterioration Events.
Lead sponsor
Brainmarc Ltd.
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2015
Completion date
January 5, 2017
Enrollment
37 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

depression